Advances in buccal drug delivery

Critical Reviews in Therapeutic Drug Carrier Systems

Volumn 22, Issue 3, 2005, Pages 295-330

  Birudaraj, Raj ^a,b   Mahalingam, Ravichandran ^a   Li, Xiaoling ^a   Jasti, Bhaskara R ^a  

^a UNIVERSITY OF THE PACIFIC   (United States)

^b ROCHE BIOSCIENCE   (United States)

Author keywords

Buccal; Enhancement; Mucosa; Permeation pathways

Indexed keywords

ACICLOVIR; BUSERELIN; BUSPIRONE; ERGOTAMINE TARTRATE; ESTRADIOL; FLECAINIDE ACETATE; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; INSULIN; ISIS 3082; LAUROCAPRAM; LIDOCAINE; MORPHINE SULFATE; OCTREOTIDE; PROPRANOLOL; RECOMBINANT ALPHA INTERFERON; SALICYLIC ACID; TRIAMCINOLONE ACETONIDE;

ACTIVE TRANSPORT; ADHESION; CHEEK MUCOSA; CHEMICAL BOND; CONTROLLED RELEASE FORMULATION; DEVICE; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG TRANSPORT; ELECTRON TRANSPORT; HUMAN; NONHUMAN; PATIENT COMPLIANCE; PERMEABILITY BARRIER; PHAGOCYTOSIS; PINOCYTOSIS; REVIEW; SLOW RELEASE FORMULATION; THEORY; ANIMAL; BUCCAL DRUG ADMINISTRATION; DRUG DOSAGE FORM; METABOLISM; METHODOLOGY; MOUTH MUCOSA; PHYSIOLOGY;

ADMINISTRATION, BUCCAL; ANIMALS; DOSAGE FORMS; DRUG DELIVERY SYSTEMS; HUMANS; MOUTH MUCOSA;

EID: 23844472042     PISSN: 07434863     EISSN: None     Source Type: Journal    
DOI: 10.1615/CritRevTherDrugCarrierSyst.v22.i3.20     Document Type: Review

References (148)

1. Harris D, Robinson JR. Drug delivery via the mucous membranes of the oral cavity. J Pharm Sci 1992; 81(1):1-10.
2. Gandhi R, Robinson, J. Oral cavity as a site for bioadhesive drug delivery. Adv Drug Del Rev 1999; 13:43-74.
3. Veillard M, Antony, F. Buccal and gastrointestinal drug delivery systems. In: Gurny R, Junginger HE, editors. Bioadhesion-Possibilities and Future Trends. Stuttgart: Wissenschaftliche Verlagsgesellschaft; 1990, 124.
4. Squier CA, Nanny D. Measurement of blood flow in the oral mucosa and skin of the rehesus monkey using radiolabelled microspheres. Arch Oral Biol 1985; 30:313.
5. Law S, Wertz PW, Swartzendruber DC, Squier CA. Regional variation in content, composition and organization of porcine epithelial barrier lipids revealed by thin-layer chromatography and transmission electron microscopy. Arch Oral Biol 1995; 40(12): 1085-1091.
6. Garren KW, Repta, A. J. Buccal drug absorption I. Comparative levels of esterases and peptidase activities in rat and hamster buccal and intestinal homogenates. Int J Pharmacol 1988; 48:189.
7. Nielsen HM, Rassing MR. TR146 cells grown on filters as a model of human buccal epithelium: V. Enzyme activity of the TR146 cell culture model, human buccal epithelium and porcine buccal epithelium, and permeability of leu- enkephalin [In Process Citation]. Int J Pharm 2000; 200(2):261-270.
8. Rathbone M, Drummond B, Tucker I. The oral cavity as a site for systemic drug delivery. Adv Drug Deliv Rev 1994; 13:1-22.
9. Levker RM. Membrane-coating granules: the fate of the discharged lamellae. J Ultrastruct Res 1976; 55:79.
10. Squier CA. Membrane-coating granules in non-keratinized oral epithelium. J Ultrastruct Res 1977; 60:212.
11. Ho NF, Barsuhn CL, Burton SP, Merkle HP. Routes of delivery: case studies. (3) Mechanistic insights to bucccal delivery of proteinaceous substances. Adv Drug Deliv Rev 1992; 8:197-235.
12. Veuillez F, Kalia YN, Jacques Y, Deshusses J, Buri PA. Factors and strategies for improving buccal absorption of peptides. Eur J Pharm Biopharm 2001; 51:93-109.
13. Garren K, Repta A. Buccal drug absorption. I. Comparative levels of esterase and peptidase activities in rat and hamster buccal and intestinal homogenates. Int J Pharm 1988; 48:189-194.
14. Hunjan MK, Evered DF. Absorption of glutathione from the gastro-intestinal tract. Biochim Biophys Acta 1985; 815:184-188.
15. Tucker GI, Dowty EM, Veillard M, Longer AM, Robinson JR. Reversed phase HPLC analysis of oligoglycine (one to six amino acid residues). Pharm Res 1989; 6: 100-102.
16. Kashi DS, Lee VHL. Enkephalin hydrolysis in homogenates of various absorptive mucosae of the albino rabbit: similarities in rates and involvement of aminopeptidases. Life Sci 1986; 38:2019-2028.
17. Stratford RE, Lee VHL. Aminopeptidase activity in homogenates of various absorptive mucosae in the albino rabbit: implications in peptide delivery. Int J Pharm 1986; 30:73-82.
18. Wearly LL. Recent progress in protein and peptide delivery by noninvasive routes. Crit Rev Ther Drug Carrier Syst 1991; 8:331-394.
19. Dowty EM, Knuth EK, Irons KB, Robinson RJ. Transport of thyrotropin releasing hormone in rabbit buccal mucosa in vitro. Pharm Res 1992; 9(9):1113-1122.
20. Zhou HX, Po ALM. Comparison of enzyme activities of tissues lining portals absorption of drugs: species differences. Int J Pharm 1991; 70:271-283.
21. Zhou HX, Po ALM. Comparison of enzymatic activities of tissues lining portals of drug absorption, using the rat as a model. Int J Pharm 1990; 62:259-267.
22. Yamamoto A, Hayakawa E, Lee VHL. Insulin and proinsulin proteolysis in mucosal homogenates of the albino rabbit: implications in peptide delivery from nonoral routes. Life Sci 1990; 47:2465-2474.
23. Lee VHL, Yamamoto A. Penetration and enzymatic to peptide and protein absorption. Adv Drug Deliv Rev 1990; 4:171-207.
24. Watanabe T, Ohata N, Morishita M, Iwamoto Y. Correlation between the protease activities and the number of epithelial cells in human saliva. J Dent Res 1981; 60: 1039-1044.
25. Squier CA, Hall BK. The permeability of mammalian non-keratinized oral epithelia to horseraddish peroxidase applied in vivo and in vitro. Arch Oral Biol 1984; 29: 45-50.
26. Squier CA, Rooney, L. The permeability of keratinised and non-keratinised oral epithelium to lanthanum in vivo. J Ultrastruct Res 1976; 54:286-295.
27. Alfano MC, Chasens AJ, Masi CW. Autoradiographic study of the penetration of radiolabelled dextrans and inulin through non-keratinized oral mucosa in vitro. J Periodont Res 1977; 12:368-377.
28. Hoogstraate AJ, Cullander C, Nagelkerke JF, Senel S, Verhoef JC, Junginger HE, et al. Diffusion rates and transport pathways of fluorescein isothiocyanate (FITC)-labeled model compounds through buccal epithelium. Pharm Res 1994; 11(1):83-89.
29. Imbert D, Cullander C. Buccal mucosa in vitro experiments. I. Confocal imaging of vital staining and MTT assays for the determination of tissue viability. J Control Release 1999; 58:39-50.
30. Marttin E, Verhoef JC, Cullander C, Romeijn SG, Nagelkerke JF, Merkus FW. Confocal laser scanning microscopic visualization of the transport of dextrans after nasal administration to rats: effects of absorption enhancers. Pharm Res 1997; 14(5): 631-637.
31. Marttin E, Verhoef JC, Spies F, van der Meulen J, Nagelkerke JF, Koerten HK, et al. The effect of methylated beta-cyclodextrins on the tight junctions of the rat nasal respiratory epithelium: electron microscopic and confocal laser scanning microscopic visualization studies. J Control Release 1999; 57(2):205-213.
32. Kitano M, Maitani Y, Takayama K, Nagai T. Buccal absorption through golden hamster cheek pouch in vitro and in vivo of 17-beta-estradiol from hydrogel containing three types of absorption enhancers. Int J Pharm 1998; 174:19-28.
33. Squier CA, Lesch CA. Penetration pathways of different compounds through epidermis and oral epithelia. J Oral Pathol 1988; 17(9-10):512-516.
34. Xu HB, Huang KX, Zhu Y-S, Gao Q-H, Wu Q-Z, Tian W-Q, Sheng X-Q, Chen Z-X, Gao Z-H. Hypoglycaemic effect of a novel insulin buccal formulation on rabbits. Pharmacol Res 2002; 46(5):459-467.
35. Birudaraj R, Steve S, Berner B, Li X. Buccal permeation of buspirone: mechanistic studies on transport pathways. J Pharm Sci 2005; 94(1):70-78.
36. Shojaei HA. Buccal mucosa as a route for systemic drug delivery: a review. J Pharm Pharma Sci 1998; 1(1):15-30.
37. Shojaei HA, Berner B, Li X. Transbuccal delivery of acyclovir: in vitro determination of routes of buccal transport. Pharm Res 1998; 15:1182-1188.
38. Saberi T, and Audus LK. Physicochemical factors affecting beta-adrenergic antagonist permeation across cultured hamster pouch buccal epithelium. Int J Pharmacol 1989; 56:135.
39. Kurosaki Y, Yano K, Kimura T. Perfusion cells for studying regional variation in oral mucosal permeability in humans. 2. A specialized transport mechanism in D-glucose absorption exists in dorsum of tongue. J Pharm Sci 1998; 87(5):613-615.
40. Kimura T, Yamano H, Tanaka A, Matsumura T, Ueda M, Ogawara K, et al. Transport of D-glucose across cultured stratified cell layer of human oral mucosal cells. J Pharm Pharmacol 2002; 54(2):213-219.
41. Utoguchi N, Watanabe Y, Suzuki T, Maehara J, Matsumoto Y, Matsumoto M. Carrier-mediated transport of monocarboxylic acids in primary cultured epithelial cells from rabbit oral mucosa. Pharm Res 1997; 14(3):320-324.
42. Utoguchi N, Magnusson M, Audus KL. Carrier-mediated transport of monocarboxylic acids in BeWo cell monolayers as a model of the human trophoblast. J Pharm Sci 1999; 88(12):1288-1292.
43. Beckett AH, Moffat AC. Correlation of partition coefficients in n-heptane-aqueous systems with buccal absorption data for a series of amines and acids. J Pharm Pharmacol 1969; 21(Suppl):144S-150S.
44. Beckett AH, Triggs EJ. Buccal absorption of basic drugs and its application as an in vivo model of passive drug transfer through lipid membranes. J Pharm Pharmacol 1967; 19(Suppl):31S-41S.
45. Birudaraj R. Transbuccal drug delivery: in vitro characterization of transport pathway of buspirone and bioadhesive drug delivery system [Dissertation]. Stockton: University of the Pacific; 2001.
46. Mahmood I, Sahajwalla C. Clinical pharmacokinetics and pharmacodynamics of buspirone, an anxiolytic drug. Clin Pharmacokinet 1999; 36(4):277-287.
47. Chen H, Chetty JD, Chien WY. A mechanistic analysis to characterize oramucosal permeation properties. Int J Pharm 1999; 184:63-72.
48. Jasti BR, Zhou S, Mehta RC, Li X. Permeability of antisense oligonucleotide through porcine buccal mucosa. Int J Pharm 2000; 208(1-2):35-39.
49. Shojaei AH, Berner B, Xiaoling L. Transbuccal delivery of acyclovir: I. In vitro determination of routes of buccal transport. Pharm Res 1998; 15(8):1182-1188.
50. Deneer VHM, Drese GB, Roemele PEH, Verhoef JC, Lie-A-Huen L, Kingma JH, et al. Buccal transport of flecainide and sotalol: effect of a bile salt and ionization state. Int J Pharm 2002; 241:127-134.
51. Hanne MN, Margrethe RR. TR 146 cells grown on filters as a human buccal epithelium: III. Permeability enhancement by different pH values, different osmolarity values, and bile salts. Int J Pharm 1999; 185:215-225.
52. Jun X, Xiaoling F, Xiaoling L. Transbuccal delivery of 2′,3′-dideoxycytidine: in vitro permeation study and histological investigation. Int J Pharm 2002; 231:57-66.
53. Hoogstraate A, Coos Verhoef J, Pijpers A, van Leengoed L, Verheijden J, Junginger H, et al. In vivo buccal delivery of the peptide drug buserelin with glycodeoxycholate as an absorption enhancer in pigs. Pharm Res 1996; 13(8):1233-1237.
54. Hoogstraate A, Verhoef J, Tuk B, Pijpers A, van Leengoed L, Verheijden J, et al. In-vivo buccal delivery of fluorescein isothiocyanate-dextran 4400 with glycodeoxycholate as an absorption enhancer in pigs. J Pharm Sci 1996; 85(5):457-460.
55. Senel S, Capan Y, Sargon MF. Enhancement of transbuccal permeation of morphine sulfate by sodium glycodeoxycholate in vitro. J Control Release 1997; 45:153-162.
56. Junginger H, Hoogstraate J, Verhoef J. Recent advances in buccal drug delivery and absorption-in vitro and in vivo studies. J Control Release 1999; 62:149-159.
57. Senel S, Hoogstraate A, Spies F, Verhoef J, Bodde H. Enhancement of in vitro permeability of porcine buccal mucosa by bile salts: kinetic and histological studies. J Control Release 1994; 32:45-56.
58. Jasti B, Zhou S, Mehta R, Li X. Permeability of antisense oligonucleotide through porcine buccal mucosa. Int J Pharm 2000; 208(1-2):35-39.
59. Deneer V, Drese G, Roemelé P, Verhoef JC, Lie-A-Huen L, Kingma J, et al. Buccal transport of flecainide and sotalol: effect of a bile salt and ionization state. Int J Pharm 2002; 241(1):127-134.
60. Senel S, Duchene D, Hincal A, Capan Y, Ponchel G. In vitro studies on enhancing effect of sodium glycocholate on transbuccal permeation of morphine hydrochloride. J Control Release 1998; 51:107-113.
61. Shin S, Bum J, Choi J. Enhanced bioavailability by buccal administration of triamcinolone acetonide from the bioadhesive gels in rabbits. Int J Pharm 2000; 209(1-2): 37-43.
62. Shin S, Kim J. Enhanced permeation of triamcinolone acetonide through the buccal mucosa. Eur J Pharm Biopharm 2000; 50(2):217-220.
63. Steward A, Bayley D, Howes C. Effect of enhancers on the buccal absorption of hybrid (BDBB) alpha-interferon. Int J Pharm 1994; 104:145-149.
64. Ogiso T, Iwaki M, Paku T. Effect of various enhancers on transdermal penetration of indomethacin and urea, and relationship between penetration parameters and enhancement factors. J Pharm Sci 1995; 84:482-488.
65. Lee J, Kellaway IW. Combined effect of oleic acid and polyethylene glycol 200 on buccal permeation of [D-Ala2, D-Leu5]enkephalin from a cubic phase of glyceryl monooleate. Int J Pharm 2000; 204(1-2):137-144.
66. Tsutsumi K, Obata Y, Takayama K, Loftsson T, Nagai T. Effect of cod-liver oil extract on the buccal permeation of ergotamine tartrate. Drug Dev Ind Pharm 1998; 24(8): 757-762.
67. Lee J, Kellaway IW. Buccal permeation of [D-Ala(2), D-Leu(5)]enkephalin from liquid crystalline phases of glyceryl monooleate. Int J Pharm 2000; 195(1-2):35-38.
68. Ceschel GC, Maffei P, Moretti MD, Demontis S, Peana AT. In vitro permeation through porcine buccal mucosa of Salvia desoleana Atzei & Picci essential oil from topical formulations. Int J Pharm 2000; 195(1-2):171-177.
69. Quintanar A, Guerrero D, Rieg F, Buri P. Ex vivo oral mucosalpermeation of lidocaine hydrochloride with sucrose fatty acid esters as absorption enhancers. Int J Pharm 1998; 173:203-210.
70. Kitano M, Maitani Y, Takayama K, Nagai T. Buccal absorption through golden hamster cheek pouch in vitro and in vivo of 17-estradiol from hydrogels containing three types of absorption enhancers. Int J Pharm 1998; 174(1-2):19-28.
71. Bendas B, Schmalfub U, Nuebert R. Influence of propylene glycol as cosolvent on mechanism of drug transport from hydrogels. Int J Pharm 1995; 116:19-30.
72. Quintanar A, Kalia Y, Rieg F, Buri P. Mechanisms of oral permeation enhancement. Int J Pharm 1997; 156(2):127-142.
73. Nicolazzo JA, Reed BL, Finnin BC. Assessment of the effects of sodium dodecyl sulfate on the buccal permeability of caffeine and estradiol. J Pharm Sci 2004; 93(2): 431-440.
74. Aungst B, Rogers N. Comparison of the effects of various transmucosal absorption promoters on buccal insulin delivery. Int J Pharm 1989; 53:227-235.
75. Araki M, Yamashita S, Nadai T, Masada M, Kurosaki Y, Nakayama T, et al. Interaction of percutaneous absorption enhancer with stratum corneum of hamster cheek pouch; an electrophysiological study. Int J Pharm 1992; 81:39-47.
76. Kurosaki Y, Hisaichi S, Nakayama T, Kimura T. Enhancing effect of 1-dodecylazacycloheptan-2-one (Azone) on the absorption of salicylic acid from keratinized oral mucosa and the duration of enhancement in vivo. Int J Pharm 1989; 51:47-54.
77. Turunen T, Urtti A, Paronen P, Audus K, Rytting J. Effect of some penetration enhancers on epithelial membrane lipid domains: evidence from fluorescence spectroscopy studies. Pharm Res 1994; 11:288-294.
78. Sandri G, Rossi S, Ferrari F, Bonferoni M, Muzzarelli C, Caramella C. Assessment of chitosan derivatives as buccal and vaginal penetration enhancers. Eur J Pharm Sci 2004; 2(2-3):351-359.
79. Schipper NG, Varum KM, Artursson P. Chitosans as absorption enhancers for poorly absorbable drugs. 1: Influence of molecular weight and degree of acetylation on drug transport across human intestinal epithelial (Caco-2) cells. Pharm Res 1996; 13(11): 1686-1692.
80. Dodane V, Amin Khan M, Merwin J. Effect of chitosan on epithelial permeability and structure. Int J Pharm 1999; 182(1):21-32.
81. Pitha J, Harma S, Michel M. Hydrophilic cyclodextrin derivatives enable effective oral administration of steroidal hormones. J Pharm Sci 1986; 75:165-167.
82. Stewart A, Bayley D, Howes C. The effect of enhancers on the buccal absorption of hybrid (BDBB) alpha-interfon. Int J Pharm 1994; 104:145-149.
83. Ritschel WA, Ritschel GB, Forusz H, Kraeling M. Buccal absorption of insulin in the dog. Res Commun Chem Pathol Pharmacol 1989; 63(1):53-67.
84. Xu HB, Huang KX, Zhu YS, Gao QH, Wu QZ, Tian WQ, et al. Hypoglycaemic effect of a novel insulin buccal formulation on rabbits. Pharmacol Res 2002; 46(5): 459-67.
85. Petkowicz J, Byra A, Szumilo T. Hypoglycemic effect of liposome-entrapped insulin administered by various routes into normal rats. Pol J Pharmacol Pharm 1989; 41(4): 299-304.
86. Shojaei AH, Khan M, Lim G, Khosravan R. Transbuccal permeation of a nucleoside analog, dideoxycytidine: effects of menthol as a permeation enhancer. Int J Pharm 1999; 192(2):139-146.
87. Nicolazzo JA, Reed BL, Finnin BC. The effect of various in vitro conditions on the permeability characteristics of the buccal mucosa. J Pharm Sci 2003; 92(12): 2399-2410.
88. van der Bijl P, van Eyk AD, Thompson IO. Penetration of human vaginal and buccal mucosa by 4.4-kd and 12-kd fluorescein-isothiocyanate-labeled dextrans. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998; 85(6):686-691.
89. Aungst BJ, Rogers NJ. Site dependence of absorption-promoting actions of laureth-9, Na salicylate, Na2EDTA, and aprotinin on rectal, nasal, and buccal insulin delivery. Pharm Res 1988; 5(5):305-308.
90. Hosny EA, Elkheshen SA, Saleh SI. Buccoadhesive tablets for insulin delivery: in-vitro and in-vivo studies. Boll Chim Farm 2002; 141(3):210-217.
91. Whittle BJ, Makki KA, O'Grady J. Changes in potential difference across the human buccal mucosa with buffered or unbuffered aspirin and salicylate. Gut 1981; 22(10): 798-803.
92. Weerapradist W, Boonpuknavig V. Effect of betel nut on the buccal mucosa of the hamster cheek pouch: comparative histological study of Thai and Indian betel nut and di-methyl benzanthracene (DMBA). J Dent Assoc Thai 1983; 33(2):53-66.
93. Chickering ED III, Mathiowitz E. Definations, mechanisms, and theories of bioadhesion. In: Mathiowitz E, Chickering ED III, Lehr C, editors. Bioadhesive Drug Delivery Systems. New York: Mercel Dekker, 1999.
94. Ishida M, Nambu N, Nagai T. Chem Pharm Bull 1983; 31:1010-1014.
95. Lehr C-M, Bouwstra JA, Bodde HE, Junginger HE. A surface energy analysis of mucoadhesion: contact angle measurments on polycarbophil and pig intestinal mucosa in physiologically relevant fluids. Pharm Res 1992; 9(1):70-75.
96. Anlar S, Capan Y, Guven O, Gogus A, Dalkara T, Hincal A. Formulation and in vitro-in vivo evaluation of buccoadhesive morphine sulfate tablets. Pharm Res 1994; 11(2):231-236.
97. Park H, Robinson JR. Physico-chemical properties of water insoluble polymers important to mucin/epithelial adhesion. J Control Release 1985; 2:47-57.
98. Park H, Robinson JR. Mechanisms of mucoadhesion of poly(acrylic acid) hydrogels. Pharm Res 1987; 4(6):457-464.
99. Park K, Cooper SL, Robinson JR. Hydrogels in Medicine and Pharmacy. Boca Raton FL: CRC Press, 1987.
100. Ameye D, Voorspoels J, Foreman P, Tsai J, Richardson P, Geresh S, et al. Ex vivo bioadhesion and in vivo testosterone bioavailability study of different bioadhesive formulations based on starch-g-pory(acrylic acid) copolymers and starch/poly(acrylic acid) mixtures. J Control Release 2002; 79(1-3):173-182.
101. Geresh S, Gdalevsky GY, Gilboa I, Voorspoels J, Remon JP, Kost J. Bioadhesive grafted starch copolymers as platforms for peroral drug delivery: a study of theophylline release. J Control Release 2004; 94(2-3):391-399.
102. Langoth N, Kalbe J, Bernkop-Schnürch A. Development of buccal drug delivery systems based on a thiolated polymer. Int J Pharm 2003; 252(1-2):141-148.
103. Kurosaki Y, Hisaichi S, Nakayama T, Kimura T. Enhancing effect of 1-dodecylazacycloheptan-2-one (Azone) on the absorption of salicyclic acid from keratinized oral mucosa and the duration of enhancement in vivo. Int J Pharm 1989; 51:47-54.
104. Shojaei A, Li X. Mechanisms of buccal mucoadhesion of novel copolymers of acrylic acid and polyethylene glycol monomethylether monomethacrylate. J Control Release 1997; 47:151-161.
105. Tur K, Ch'ng H. Evaluation of possible mechanisms of bioadhesion. Int J Pharm 1998; 160:61-74.
106. Rao KVR, Buri P. Novel in situ method to test polymers and coated microparticles for bioadhesion. Int J Pharm 1989; 52:265-270.
107. Huntsberger JR. Treatise on Adhesion and Adhesives. New York: Mercel Dekker, 1967.
108. Hiemenz PC. Principles of Colloid and Surface Chemistry. New York: Marcel Dekker, 1977.
109. Voyutskii SS. Autohesion and Adhesion of High Polymers. New York: Wiley, 1963.
110. Mikos AG, Peppas NA. Measurement of the surface tension of mucin solutions. Int J Pharm 1989; 53:1-5.
111. Huang Y, Leobandung W, Foss A, Peppas NA. Molecular aspects of muco- and bioadhesion: tethered structures and site-specific surfaces. J Control Release 2000; 65(1-2):63-71.
112. Peppas NA. Devices based on intelligent biopolymers for oral protein delivery. Int J Pharm 2004; 277(1-2):11-17.
113. Bogataj M, Vovk T, Kerec M, Dimnik A, Grabnar I, Mrhar A. The correlation between zeta potential and mucoadhesion strength on pig vesical mucosa. Biol Pharm Bull 2003; 26(5):743-746.
114. Ahagon A, Gent AN. Effect of interfacial bonding on the strength of adhesion. J Polym Sci Polym Phys Ed 1975; 13:1285-1300.
115. Mathowitz E, Chickering D, Jacob J, Santos C. Bioadhesive drug delivery systems. In: Mathiowitz E, editor. Encyclopedia of Controlled Drug Delivery. New York: Wiley, 1999.
116. Peppas N, Sahlin J. Hydrogels as mucoadhesive and bioadhesive materials: a review. Biomaterials 1996; 17:1553-1561.
117. Xiang J. In vitro study of transbuccal drug delivery systems: mucoadhesion of a novel bioadhesive and permeation of zalcitabine [Dissertation]. Stockton: University of the Pacific, 2001.
118. Duchene D, Ponchel G. Bioadhesion of solid oral dosage forms, why and how? Eur J Pharm Biopharm 1997; 44(1):15-32.
119. Chien WY. Recent advances in noninvasive systemic delivery of pharmaceuticals and biopharmaceuticals. Drug Dev Ind Pharm 1994; 20(4):417-468.
120. De Vries ME, Bodde HE, Verhoef JC, Junginger HE. Developments in buccal drug delivery. Crit Rev Ther Drug Carrier Syst 1991; 8(3):271-303.
121. Steward A, Bayley DL, Howes C. The effect of enhancers on the buccal absorption of hybrid (BDBB) alpha-interferon. Int J Pharm 1994; 104:145-149.
122. Bayley D, Temple C, Clay V, Steward A, Lowther N. The transmucosal absorption of recombinant human interferon-alpha B/D hybrid in the rat and rabbit. J Pharm Pharmacol 1995; 47:721-724.
123. Alur HH, Bael JD, Pather SI, Mitra AK, Johnston TP. Evaluation of a novel, natural oligosaccharide gum as a sustained-release and mucoadhesive component of calcitonin buccal tablets. J Pharm Sci 1999; 88(12):1313-1319.
124. Sayani AP, Chien YW. Systemic delivery of peptides and proteins across absorptive mucosae. Crit Rev Ther Drug Carrier Syst 1996; 13(1-2):85-184.
125. Alur H, Pather I, Mitra A, Johnston T. Transmucosal sustained-delivery of chlorpheniramine maleate in rabbits using a novel, natural mucoadhesive gum as an excipient in buccal tablets. Int J Pharm 1999; 188:1-10.
126. Shojaei A, Khan M, Lim G, Khosravan R. Transbuccal permeation of a nucleoside analog, dideoxycytidine: effects of menthol as a permeation enhancer. Int J Pharm 1999; 192:139-146.
127. Xiang J, Fang X, Li X. Transbuccal delivery of 2′,3′- dideoxycytidine: in vitro permeation study and histological investigation. Int J Pharm 2002; 231:57-66.
128. Oh CK, Ritschel WA. Biopharmaceutic aspects of buccal absorption of insulin. Meth Find Exp Clin Pharmacol 1990; 12(3):205-212.
129. Nakane S, Kakumoto M, Yukimatsu K, Chien YW. Oramucosal delivery of LHRH: pharmacokinetic studies of controlled and enhanced transmucosal permeation. Pharm Dev Technol 1996; 1(3):251-259.
130. Senel S, Dauchene D, Hincal A, Capan Y, Ponchel G. In vitro studies on enhancing effects of sodium glycocholate on transbuccal permeation of morphine hydrochloride. J Control Rel 1998; 51:107-113.
131. Han R, Fang J, Sung K, Hu O. Mucoadhesive buccal disks for novel nalbuphine prodrug controlled delivery: effect of formulation variables on drug release and mucoadhesive performance. Int J Pharm 1999; 177:201-209.
132. Wolany GJM, Munzer J, Rummelt A, Merkle HP. Buccal absorption of Sandostatin (octreotide) in conscious beagle dogs. Proc Int Symp Control Rel Bioact Mater 1990; 17:224-225.
133. Coutel-Egros A, Maitani Y, Veillard M, Machida Y, Nagai T. Combined effects of pH, cosolvent and penetration enhancers on the in vitro buccal absorption of propranolol through excised hamster cheek pouch. Int J Pharm 1992; 84:117-128.
134. Manganaro A. The effects of permeabilizers on the in vitro penetration of propranolol through porcine buccal epithelium. Military Med 1996; 161(11):669-672.
135. Kurosaki Y, Hisaichi S, Hong L, Nakayama T, Kimura T. Enhanced permeability of keratinized oral-mucosa to salicylic acid with 1-dodecylacycloheptan-2-one (Azone). In vitro studies in hamster cheek pouch. Int J Pharm 1989; 49:47-55.
136. Gandhi R, Robinson J. Mechanism of penetration enhancement for transbuccal delivery of salicylic acid. Int J Pharm 1992; 85:129-140.
137. Nielsen HM, Rassing MR. TR146 cells grown on filters as a model of human buccal epithelium: IV. Permeability of water, mannitol, testosterone and beta-adrenoceptor antagonists. Comparison to human, monkey and porcine buccal mucosa. Int J Pharm 2000; 194(2):155-167.
138. Voorspoels J, Remon J, Willy E, Sy W. Buccal absorption of testosterone and its esters using a bioadhesive tablet in dogs. Pharm Res 1996; 13(8):1228-1232.
139. Tsutsumia KYO, Nagaia TA, Thorsteinn L, Takayamaa K. Buccal absorption of ergotamine tartrate using the bioadhesive tablet system in guinea-pigs. Int J Pharm 2002; 238(1-2):161-170.
140. Iga K, Ogawa Y. Sustained-release buccal dosage forms for nitroglycerin and isosorbide dinitrate: increased bioavailability and extended time of absorption when administered to dogs.J Control Release 1997; 49(2-3):105-113.
141. Park CR, Munday DL. Development and evaluation of a biphasic buccal adhesive tablet for nicotine replacement therapy. Int J Pharm 2002; 237(1-2):215-226.
142. Lee Y, Chien YW. Oral mucosa controlled delivery of LHRH by bilayer mucoadhesive polymer systems. J Control Release 1995; 37(I3):251-261.
143. Senel S, Ikinci G, Kas S, Rad A, Sargon MF, Hincal AA. Chitosan films and hydrogels of chlorhexidine gluconate for oral mucosal delivery. Int J Pharm 2000; 193(2): 197-203.
144. López CR, Portero A, Vila-Jato JL, Alonso MJ. Design and evaluation of chitosan/ethylcellulose mucoadhesive bilayered devices for buccal drug delivery. J Control Release 1998; 55(2-3):143-152.
145. Peppas AN. Mathematical models for controlled release kinetics. In: Langer R, Wise D, editors. Medical Application of Controlled Release. Florida: CRC Press, 1984.
146. Jinsong H, Heng SWP. Buccal delivery systems. Drug Dev Ind Pharm 2003; 29(8): 821-832.
147. Frenning G, Ek R, Stromme M. A new method for characterizing the release of drugs from tablets in low liquid surroundings. J Pharm Sci 2002; 91(3):776-784.
148. Kvist C, Anderson B, Fors S, Wennergren B, Burglund J. Apparatus for studying in vitro drug release from medicated chewing gums. Int J Pharm 1999; 189(1):57-65.